|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rawla P, Sunkara T and Gaduputi V:
Epidemiology of pancreatic cancer: Global trends, etiology and risk
factors. World J Oncol. 10:10–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen G, Guo GQ, Zhou XD and Chen HX:
Potential mechanism of ferroptosis in pancreatic cancer. Oncol
Lett. 19:579–587. 2020.PubMed/NCBI
|
|
5
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 5:1060–1072. 2012. View Article : Google Scholar
|
|
6
|
Kajarabille N and Latunde-Dada GO:
Programmed cell-death by ferroptosis: Antioxidants as mitigators.
Int J Mol Sci. 19:49682019. View Article : Google Scholar
|
|
7
|
Hasegawa M, Takahashi H, Rajabi H, Alam M,
Suzuki Y, Yin L, Tagde A, Maeda T, Hiraki M, Sukhatme VP and Kufe
D: Functional interactions of the cystine/glutamate antiporter,
CD44v and MUC1-C oncoprotein in triple-negative breast cancer
cells. Oncotarget. 7:11756–11769. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin R, Zhang Z, Chen L, Zhou Y, Zou P,
Feng C, Wang L and Liang G: Dihydroartemisinin (DHA) induces
ferroptosis and causes cell cycle arrest in head and neck carcinoma
cells. Cancer Lett. 381:165–175. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang M, Chen Z, Wu D and Chen L:
Ferritinophagy/ferroptosis: Iron-related newcomers in human
diseases. J Cell Physiol. 233:9179–9190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nie J, Lin B, Zhou M, Wu L and Zheng T:
Role of ferroptosis in hepatocellular carcinoma. J Cancer Res Clin
Oncol. 144:2329–2337. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xia XJ, Fan XP, Zhao MY and Zhu P: The
relationship between ferroptosis and tumors-a novel landscape for
therapeutic approach. Curr Gene Ther. 19:117–124. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamaguchi Y, Kasukabe T and Kumakura S:
Piperlongumine rapidly induces the death of human pancreatic cancer
cells mainly through the induction of ferroptosis. Int J Oncol.
3:1011–1022. 2018.
|
|
13
|
Wang K, Zhang Z, Wang M, Cao X, Qi J, Wang
D, Gong A and Zhu H: Role of GRP78 inhibiting artesunate-induced
ferroptosis in KRAS mutant pancreatic cancer cells. Drug Des Devel
Ther. 13:2135–2144. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song Z, Xiang X, Li J, Deng J, Fang Z,
Zhang L and Xiong J: Ruscogenin induces ferroptosis in pancreatic
cancer cells. Oncol Rep. 43:516–524. 2020.PubMed/NCBI
|
|
15
|
Binenbaum Y, Na'ara S and Gil Z:
Gemcitabine resistance in pancreatic ductal adenocarcinoma. Drug
Resist Updat. 23:55–68. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu S, Zhang Q, Sun X, Zeh HJ III, Lotze
MT, Kang R and Tang D: HSPA5 regulates ferroptotic cell death in
cancer cells. Cancer Res. 77:2064–2077. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dong JT, Lamb PW, Rinker-Schaeffer CW,
Vukanovic J, Ichikawa T, Isaacs JT and Barrett JC: KAI1, a
metastasis suppressor gene for prostate cancer on human chromosome
11p11.2. Science. 268:884–886. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo XZ, Friess H, Shao XD, Liu MP, Xia YT,
Xu JH and Buchler MW: KAI1 gene is differently expressed in
papillary and pancreatic cancer influence on metastasis. World J
Gastroenterol. 6:866–871. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu JH, Guo XZ, Ren LN, Shao LC and Liu MP:
KAI1 is potential target on anti-metastasis in pancreatic cancer
cells. World J Gastroenterol. 14:1126–1132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Guo XZ, Zhang WW, Lu ZZ, Zhang QW,
Duan HF and Wang LS: KAI1 inhibits HGF-induced invasion of
pancreatic cancer by sphingosine kinase activity. Hepatobiliary
Pancreat Dis Int. 10:201–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Guo XZ, Li HY, Chen J, Ren LN and
Wu CY: KAI1 inhibits lymphangiogenesis and lymphatic metastasis of
pancreatic cancer in vivo. Hepatobiliary Pancreat Dis Int.
13:87–92. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu X, Guo X, Li H, Chen J and Qi X:
Src/STAT3 signaling pathways are involved in KAI1-induced
downregulation of VEGF-C expression in pancreatic cancer. Mol Med
Report. 13:4774–4778. 2016. View Article : Google Scholar
|
|
23
|
Liu X, Guo XZ, Li HY and Chen J: KAI1
reverses the epithelial-mesenchymal transition in human pancreatic
cancer cells. Hepatobiliary Pancreat Dis Int. 18:471–477. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu CY, Yan J, Yang YF, Xiao FJ, Li QF,
Zhang QW, Wang LS, Guo XZ and Wang H: Overexpression of KAI1
induces autophagy and increases MiaPaCa-2 cell survival through the
phosphorylation of extracellular signal-regulated kinases. Biochem
Biophys Res Commun. 404:802–808. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu CY, Guo XZ and Li HY: Hypoxia and serum
deprivation protected MiaPaCa-2 cells from KAI1-induced
proliferation inhibition through autophagy pathway activation in
solid tumors. Clin Transl Oncol. 17:201–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh
HJ III, Kang R and Tang D: Autophagy promotes ferroptosis by
degradation of ferritin. Autophagy. 12:1425–1428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou B, Liu J, Kang R, Klionsky DJ,
Kroemer G and Tang D: Ferroptosis is a type of autophagy-dependent
cell death. Semin Cancer Biol. 66:89–100. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao AC, Lou W, Dong JT, Barrett JC,
Danielpour D and Isaacs JT: Defining regulatory elements in the
human KAI1 (CD 82) metastasis suppressor gene. Prostate.
57:256–260. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu B, Chen XB, Ying MD, He QJ, Cao J and
Yang B: The role of ferroptosis in cancer development and treatment
response. Front Pharmacol. 8:9922018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dixon SJ and Stockwell BR: The role of
iron and reactive oxygen species in cell death. Nat Chem Biol.
10:9–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao
N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell
Death Dis. 11:882020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mou Y, Wang J, Wu J, He D, Zhang C, Duan C
and Li B: Ferroptosis, a new form of cell death: Opportunities and
challenges in cancer. J Hematol Oncol. 12:34–50. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Camaschella C, Nai A and Silvestri L: Iron
metabolism and iron disorders revisited in the hepcidin era.
Haematologica. 105:260–272. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Manz DH, Blanchette NL, Paul BT, Torti FM
and Torti SV: Iron and cancer: Recent insights. Ann N Y Acad Sci.
1368:149–161. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Petronek MS, Spitz DR, Buettner GR and
Allen BG: Linking cancer metabolic dysfunction and genetic
instability through the lens of iron metabolism. Cancers (Basel).
11:10772019. View Article : Google Scholar
|
|
37
|
Kazan HH, Urfali-Mamatoglu C and Gunduz U:
Iron metabolism and drug resistance in cancer. Biometals.
30:629–641. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Thévenod F: Iron and its role in cancer
defense: A double-edged sword. Met Ions Life Sci. 18:2018.
|
|
39
|
Chen Y, Fan Z, Yang Y and Gu C: Iron
metabolism and its contribution to cancer (Review). Int J Oncol.
54:1143–1154. 2019.PubMed/NCBI
|
|
40
|
Wang YF, Yu L, Ding J and Chen Y: Iron
metabolism in cancer. Int J Mol Sci. 20:952019. View Article : Google Scholar
|
|
41
|
Forcina GC and Dixon SJ: GPX4 at the
crossroads of lipid homeostasis and ferroptosis. Proteomics.
19:e18003112019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Seibt TM, Proneth B and Conrad M: Role of
GPX4 in ferroptosis and its pharmacological implication. Free Radic
Biol Med. 133:144–152. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
